Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695M
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
541M
-
Shares change
-
-11.5M
-
Total reported value, excl. options
-
$6.08B
-
Value change
-
-$144M
-
Put/Call ratio
-
0.41
-
Number of buys
-
129
-
Number of sells
-
-92
-
Price
-
$11.23
Significant Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q4 2023
283 filings reported holding ROIV - Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share as of Q4 2023.
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 541M shares
of 695M outstanding shares and own 77.88% of the company stock.
Largest 10 shareholders include QVT Financial LP (113M shares), SB INVESTMENT ADVISERS (UK) LTD (73M shares), VIKING GLOBAL INVESTORS LP (69.4M shares), FMR LLC (37M shares), MORGAN STANLEY (21.9M shares), BlackRock Inc. (20.8M shares), Rubric Capital Management LP (19M shares), STATE STREET CORP (13.7M shares), WELLINGTON MANAGEMENT GROUP LLP (13.6M shares), and Patient Square Capital LP (12.6M shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.